Important information regarding the Supply of Seprafilm ... - Sanofi

105 downloads 152 Views 30KB Size Report
Mar 13, 2013 - Talavera Corporate Centre, Building D, 12-24 Talavera Road, Macquarie Park, NSW 2113 -. Tel: +61 (0) 2 86
13 March 2013

TO WHOM IT MAY CONCERN

Dear Sir/Madam Important information regarding the Supply of Seprafilm® Adhesion Barrier Sanofi is pleased to announce that the supply of Seprafilm® Adhesion Barrier (CH2 part number: 1683133) is now available through the usual distribution channels. This means that there is no longer any requirement to request Seprafilm through the TGA’s Special Access Scheme. As Sanofi is unable to determine all users affected by this process, we kindly ask that you disseminate this information to all relevant parties within your institution. To assist with this a soft copy of this letter can also be accessed from Sanofi website: www.sanofi.com.au or www.bit.ly/SeprafilmAUS.

We apologise for any inconvenience this situation may have caused. If you would like further information regarding Seprafilm, please contact: For medical enquiries For enquiries relating to supply

Sanofi Medical Information 1800 828 806 Sanofi Customer Service 1800 640 791

Yours faithfully,

Maxence Laurent Commercial Manager

sanofi-aventis australia pty ltd trading as Sanofi ABN 31 008 558 807 Talavera Corporate Centre, Building D, 12-24 Talavera Road, Macquarie Park, NSW 2113 Tel: +61 (0) 2 8666 2000 – Fax: +61 (0) 2 8666 3000 - www.sanofi.com.au